Fundies. English
Segment disclosures
Company overviewImmudyne, Inc.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
32 dimension combinations 257 retained observations 30 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · Telehealth
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=LFMD:TelehealthMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 47281085 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 97444041 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 50162956 | USD | 20260506 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 194055198 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 47279933 | USD | 20251117 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 147186714 | USD | 20251117 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 49018882 Restated | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 99906781 Restated | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 50887899 Restated | USD | 20260506 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 154824075 Restated | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 40154683 | USD | 20251117 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 109687054 | USD | 20251117 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 37432309 | USD | 20250805 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 68273711 | USD | 20250805 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 30841402 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 98152919 | USD | 20250311 | Open filing evidence |
Operating Segments · Work Simpli
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=LFMD:WorkSimpliMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-09-30 | 12892537 | USD | 20251117 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 39788325 | USD | 20251117 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 13654513 | USD | 20250805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 26895788 | USD | 20250805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 13241275 | USD | 20250506 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 54015207 | USD | 20250311 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 13117611 | USD | 20251117 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 39650009 | USD | 20251117 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 13229536 | USD | 20250805 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 26532398 | USD | 20250805 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 13302862 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 54394087 | USD | 20250311 | Open filing evidence |
Product Revenues Net · INR Wellness · CVLBPR
Product Or Service · Statement Business Segments · Related Party Transactions By Related Party
Source dimensions
srt:ProductOrServiceAxis=CVLB:ProductRevenuesNetMember;us-gaap:StatementBusinessSegmentsAxis=CVLB:INRWellnessMember;us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=CVLB:CVLBPRMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 19875 | USD | 20201116 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 139129 | USD | 20201116 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 224730 | USD | 20201116 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 458324 | USD | 20201116 | Open filing evidence |
Product Revenues Net · Other Misc Service · CVLBPR
Product Or Service · Statement Business Segments · Related Party Transactions By Related Party
Source dimensions
srt:ProductOrServiceAxis=CVLB:ProductRevenuesNetMember;us-gaap:StatementBusinessSegmentsAxis=CVLB:OtherMiscServiceMember;us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=CVLB:CVLBPRMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 5002 | USD | 20201116 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 5002 | USD | 20201116 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 960 | USD | 20201116 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 5041 | USD | 20201116 | Open filing evidence |
Product Revenues Net · Purpurex · CVLBPR
Product Or Service · Statement Business Segments · Related Party Transactions By Related Party
Source dimensions
srt:ProductOrServiceAxis=CVLB:ProductRevenuesNetMember;us-gaap:StatementBusinessSegmentsAxis=CVLB:PurpurexMember;us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=CVLB:CVLBPRMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 16973 | USD | 20201116 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 47290 | USD | 20201116 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 7108 | USD | 20201116 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 17340 | USD | 20201116 | Open filing evidence |
Product Revenues Net · Rex MD · CVLBPR
Product Or Service · Statement Business Segments · Related Party Transactions By Related Party
Source dimensions
srt:ProductOrServiceAxis=CVLB:ProductRevenuesNetMember;us-gaap:StatementBusinessSegmentsAxis=CVLB:RexMDMember;us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=CVLB:CVLBPRMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 4008687 | USD | 20201116 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 6524247 | USD | 20201116 | Open filing evidence |
Product Revenues Net · Scarology · CVLBPR
Product Or Service · Statement Business Segments · Related Party Transactions By Related Party
Source dimensions
srt:ProductOrServiceAxis=CVLB:ProductRevenuesNetMember;us-gaap:StatementBusinessSegmentsAxis=CVLB:ScarologyMember;us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=CVLB:CVLBPRMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-09-30 | 4105 | USD | 20201116 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 25606 | USD | 20201116 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 44332 | USD | 20201116 | Open filing evidence |
Product Revenues Net · Shapiro MD · CVLBPR
Product Or Service · Statement Business Segments · Related Party Transactions By Related Party
Source dimensions
srt:ProductOrServiceAxis=CVLB:ProductRevenuesNetMember;us-gaap:StatementBusinessSegmentsAxis=CVLB:ShapiroMDMember;us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=CVLB:CVLBPRMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 5387599 | USD | 20201116 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 13543977 | USD | 20201116 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 2203361 | USD | 20201116 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 6784487 | USD | 20201116 | Open filing evidence |
Software Revenue · Legal Simpli
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=CVLB:SoftwareRevenueMember;us-gaap:StatementBusinessSegmentsAxis=CVLB:LegalSimpliMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 1567627 | USD | 20201116 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 4136608 | USD | 20201116 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 664962 | USD | 20201116 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 1214600 | USD | 20201116 | Open filing evidence |
Product · CVLBPR · Innate
Product Or Service · Related Party Transactions By Related Party · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=LFMD:CVLBPRMember;us-gaap:StatementBusinessSegmentsAxis=LFMD:InnateMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-03-31 | 9840553 | USD | 20210514 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 5041 | USD | 20210330 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 492773 | USD | 20210514 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 49258 | USD | 20210330 | Open filing evidence |
Product · CVLBPR · Nava MD
Product Or Service · Related Party Transactions By Related Party · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=LFMD:CVLBPRMember;us-gaap:StatementBusinessSegmentsAxis=LFMD:NavaMDMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-04-01 – 2021-06-30 | 108252 | USD | 20210813 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 108252 | USD | 20210813 | Open filing evidence |
Product · CVLBPR · Purpurex
Product Or Service · Related Party Transactions By Related Party · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=LFMD:CVLBPRMember;us-gaap:StatementBusinessSegmentsAxis=LFMD:PurpurexMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-04-01 – 2021-06-30 | 27466 | USD | 20210813 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 62540 | USD | 20210813 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 79426 | USD | 20210813 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 132948 | USD | 20210813 | Open filing evidence |
Product · CVLBPR · Shapiro MD
Product Or Service · Related Party Transactions By Related Party · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=LFMD:CVLBPRMember;us-gaap:StatementBusinessSegmentsAxis=LFMD:ShapiroMDMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-04-01 – 2021-06-30 | 3515631 | USD | 20210813 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 6899414 | USD | 20210813 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 5881965 | USD | 20210813 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 8219073 | USD | 20210813 | Open filing evidence |
Product · INR Wellness · CVLBPR
Product Or Service · Statement Business Segments · Related Party Transactions By Related Party
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=LFMD:INRWellnessMember;us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=LFMD:CVLBPRMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-04-01 – 2021-06-30 | 19737 | USD | 20210813 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 43642 | USD | 20210813 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 23905 | USD | 20210514 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 247350 | USD | 20210330 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 71162 | USD | 20210813 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 141090 | USD | 20210813 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 69928 | USD | 20210514 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 738965 | USD | 20210330 | Open filing evidence |
Product · Rex MD · CVLBPR
Product Or Service · Statement Business Segments · Related Party Transactions By Related Party
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=LFMD:RexMDMember;us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=LFMD:CVLBPRMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-04-01 – 2021-06-30 | 12128524 | USD | 20210813 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 21969077 | USD | 20210813 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 12969753 | USD | 20210330 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 1835503 | USD | 20210813 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 2328276 | USD | 20210813 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 2470 | USD | 20210514 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 60197 | USD | 20210330 | Open filing evidence |
Product · Scarology · CVLBPR
Product Or Service · Statement Business Segments · Related Party Transactions By Related Party
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=LFMD:ScarologyMember;us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=LFMD:CVLBPRMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-03-31 | 35074 | USD | 20210514 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 44332 | USD | 20210330 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 1757 | USD | 20210813 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 4227 | USD | 20210813 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 53522 | USD | 20210514 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 51131 | USD | 20210330 | Open filing evidence |
Product · Shapiro MD · CVLBPR
Product Or Service · Statement Business Segments · Related Party Transactions By Related Party
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=LFMD:ShapiroMDMember;us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=LFMD:CVLBPRMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-03-31 | 3383783 | USD | 20210514 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 17289687 | USD | 20210330 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 2337108 | USD | 20210514 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 9019956 | USD | 20210330 | Open filing evidence |
Product · Telehealth
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=LFMD:TelehealthMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-03-31 | 22598061 | USD | 20220513 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 68197128 | USD | 20220307 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 13283315 | USD | 20220513 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 30561163 | USD | 20220307 | Open filing evidence |
Product · Worksimpli
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=LFMD:WorksimpliMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-03-31 | 6444776 | USD | 20220513 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 24678678 | USD | 20220307 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 4914797 | USD | 20220513 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 6732747 | USD | 20220307 | Open filing evidence |
Cosmetic Goods
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=immd:CosmeticGoodsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2016-07-01 – 2016-09-30 | 1154688 | USD | 20171113 | Open filing evidence |
| 2016-01-01 – 2016-09-30 | 3494743 | USD | 20171113 | Open filing evidence |
Nutraceutical And Cosmetic
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=immd:NutraceuticalAndCosmeticMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2016-07-01 – 2016-09-30 | 229741 | USD | 20171113 | Open filing evidence |
| 2016-01-01 – 2016-09-30 | 780961 | USD | 20171113 | Open filing evidence |
| 2015-07-01 – 2015-09-30 | 279883 | USD | 20171113 | Open filing evidence |
| 2015-01-01 – 2015-09-30 | 845513 | USD | 20171113 | Open filing evidence |
Life MDPC Subscription Revenue
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=LFMD:LifeMDPCSubscriptionRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 20024954 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 41514636 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 13881894 | USD | 20240807 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 21489682 | USD | 20240807 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 7607788 | USD | 20240508 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1909800 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2703589 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 436040 | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 793789 | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 357749 | USD | 20240508 | Open filing evidence |
Medifast Collaboration Revenue
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=LFMD:MedifastCollaborationRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 5000000 | USD | 20260310 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 5000000 | USD | 20251117 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 3031250 | USD | 20250805 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 5000000 | USD | 20250805 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1968750 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 5000000 | USD | 20250311 | Open filing evidence |
Telehealth
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=LFMD:TelehealthMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 18002742 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 37757871 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 19755129 | USD | 20260506 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 80786095 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 19979502 | USD | 20251117 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 60734271 | USD | 20251117 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 19994406 Restated | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 40754768 Restated | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 20760363 Restated | USD | 20260506 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 82139528 Restated | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 19225172 Restated | USD | 20251117 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 59462336 Restated | USD | 20251117 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 20519165 | USD | 20250805 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 41784029 | USD | 20250805 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 21264864 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 88886664 Restated | USD | 20250311 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 22432989 Restated | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 64193130 Restated | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 21915088 Restated | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 41760142 Restated | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 19845054 Restated | USD | 20240508 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 82649845 | USD | 20240311 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 21365178 | USD | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 66231202 | USD | 20231108 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 22267963 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 44866024 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 22598061 | USD | 20230512 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 68197128 | USD | 20230322 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 18540897 | USD | 20221110 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 47623822 | USD | 20221110 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 15799610 | USD | 20220811 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 29082925 | USD | 20220811 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 13283315 | USD | 20220513 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 30561163 | USD | 20220307 | Open filing evidence |
Telehealth · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=LFMD:TelehealthMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 40275546 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 108549257 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 37432309 | USD | 20240807 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 68273711 | USD | 20240807 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 30841402 | USD | 20240508 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 98152919 | USD | 20240311 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 24342789 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 66896719 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 22351128 | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 42553931 | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 20202803 | USD | 20240508 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 82649845 | USD | 20240311 | Open filing evidence |
Telehealth Revenue
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=LFMD:TelehealthRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 24342789 | USD | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 66896719 | USD | 20231108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 22351128 | USD | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 42553931 | USD | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 20202803 | USD | 20230512 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 21365178 | USD | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 66231202 | USD | 20231108 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 22267963 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 44866024 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 22598061 | USD | 20230512 | Open filing evidence |
Telehealth Subscription Revenue
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=LFMD:TelehealthSubscriptionRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 29278343 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 59686170 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 30407827 | USD | 20260506 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 113269103 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 27300431 | USD | 20251117 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 86452443 | USD | 20251117 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 29024476 Restated | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 59152013 Restated | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 30127536 Restated | USD | 20260506 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 67684547 Restated | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 20929511 | USD | 20251117 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 45224718 | USD | 20251117 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 13881894 | USD | 20250805 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 21489682 | USD | 20250805 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 7607788 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 4266255 | USD | 20250311 | Open filing evidence |
Worksimpli
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=LFMD:WorksimpliMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-03-31 | 6444776 | USD | 20220513 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 24678678 | USD | 20220307 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 4914797 | USD | 20220513 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 6732747 | USD | 20220307 | Open filing evidence |
Work Simpli
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=LFMD:WorkSimpliMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-09-30 | 12892537 | USD | 20251117 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 39788325 | USD | 20251117 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 4100000 Restated | USD | 20250805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 8200000 Restated | USD | 20250805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 4100000 Restated | USD | 20250506 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 14900000 Restated | USD | 20250311 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 13117611 | USD | 20251117 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 39650009 | USD | 20251117 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 3200000 Restated | USD | 20250805 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 6700000 Restated | USD | 20250805 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 3500000 Restated | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 14000000 Restated | USD | 20250311 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 14271122 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 40790439 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 13595785 | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 26519317 | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 12923532 | USD | 20240508 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 36383675 | USD | 20240311 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 10047291 | USD | 20221110 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 24682602 | USD | 20221110 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 8190535 | USD | 20220811 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 14635311 | USD | 20220811 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 24678678 | USD | 20230322 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 6406302 | USD | 20221110 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 17835100 | USD | 20221110 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 6514001 | USD | 20220811 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 11428798 | USD | 20220811 | Open filing evidence |
Work Simpli · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=LFMD:WorkSimpliMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 13117611 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 39650009 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 13229536 | USD | 20240807 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 26532398 | USD | 20240807 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 13302862 | USD | 20240508 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 54394087 | USD | 20240311 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 14271122 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 40790439 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 13595785 | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 26519317 | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 12923532 | USD | 20240508 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 36383675 | USD | 20240311 | Open filing evidence |
Work Simpli Revenue
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=LFMD:WorkSimpliRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 14271122 | USD | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 40790439 | USD | 20231108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 13595785 | USD | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 26519317 | USD | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 12923532 | USD | 20230512 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 10047291 | USD | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 24682602 | USD | 20231108 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 8190535 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 14635311 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 6444776 | USD | 20230512 | Open filing evidence |
Work Simpli Software Llc
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=LFMD:WorkSimpliSoftwareLlcMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 14271122 | USD | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 40790439 | USD | 20231108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 13595785 | USD | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 26519317 | USD | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 12923532 | USD | 20230512 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 10047291 | USD | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 24682602 | USD | 20231108 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 8190535 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 14635311 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 6444776 | USD | 20230512 | Open filing evidence |